Health Canada, the Canadian equivalent of the U.S. Food and Drug Administration (FDA), issued an announcement in early May 2014 with new information on transvaginal mesh. Their announcement pertained specifically to those mesh devices used in the treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Health Canada supplied a list of health complications that are often identified in patient reports. Patients have suffered from:
The Canadian medical devices regulator is considering if updates to safety information for transvaginal mesh products will be necessary, according to their news release.
If any of the complications mentioned above is descriptive of your injury, Carey Danis & Lowe is here to help you. As a law firm headquartered in St. Louis that specializes in defective medical device litigation, Carey Danis & Lowe can guide you through the process of filing a lawsuit targeted at the manufacturer of your particular transvaginal mesh device.
Our experienced personal injury lawyers are available to hear your transvaginal mesh story during a free case evaluation.
Contact Carey Danis & Lowe today by phone at 800.721.2519, or by completing our personal injury claim form.References: Defective Medical Device litigation, Transvaginal Mesh